Ragosa Mark — SEC Form 4 filings
SEC reporting owner CIK 1835458. 27 Form 4 filings on record with FilingPulse; latest filed 2026-09-03.
Transaction summary — filings shown
Covers all 27 filings on record, filed 2024-04-03 to 2026-09-03. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 23 legs across 15 filings — 394,843 shares, $12,218,757 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 133.
- Largest priced transaction: sale of 42,841 shares @ $41.49 ($1,777,473) in Kiniksa Pharmaceuticals International, plc, filed 2025-12-10.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Kiniksa Pharmaceuticals International, plc (KNSA) | CHIEF FINANCIAL OFFICER | 27 | — | 23 legs · 394,843 sh · $12,218,757 | 133 |
Form 4 filings — Ragosa Mark
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-09-03 | 4 | Kiniksa Pharmaceuticals International, plc (KNSA) | Option exercise (M): 2,694 · Option exercise (M): 1,750 · Option exercise (M): 1,591 · Option exercise (M): 3,069 · Tax withholding (F): 4,404 @ $79.28 · Grant/award (A): 7,800 (derivative) @ $0 · +5 more | EDGAR |
| 2026-04-08 | 4 | Kiniksa Pharmaceuticals International, plc (KNSA) | Option exercise (M): 2,694 · Tax withholding (F): 1,303 @ $48.94 · Option exercise (M): 2,694 (derivative) @ $0 | EDGAR |
| 2026-04-03 | 4 | Kiniksa Pharmaceuticals International, plc (KNSA) | Option exercise (M): 5,187 · Tax withholding (F): 2,510 @ $48.13 · Grant/award (A): 31,150 (derivative) @ $0 · Grant/award (A): 7,800 (derivative) @ $0 · Grant/award (A): 15,600 (derivative) @ $0 · Option exercise (M): 1,750 (derivative) @ $0 · +2 more | EDGAR |
| 2026-03-11 | 4 | Kiniksa Pharmaceuticals International, plc (KNSA) | Option exercise (M): 2,036 @ $22.89 · Option exercise (M): 10,513 @ $17.76 · Option exercise (M): 13,813 @ $18.06 · Option exercise (M): 10,360 @ $26.74 · Sale (S): 17,981 @ $45.58 · Sale (S): 18,741 @ $46.24 · +4 more | EDGAR |
| 2026-02-11 | 4 | Kiniksa Pharmaceuticals International, plc (KNSA) | Option exercise (M): 8,374 @ $12.97 · Option exercise (M): 2,471 @ $16.90 · Sale (S): 9,114 @ $42.85 · Sale (S): 8,731 @ $43.72 · Option exercise (M): 8,374 (derivative) @ $0 · Option exercise (M): 2,471 (derivative) @ $0 | EDGAR |
| 2026-01-09 | 4 | Kiniksa Pharmaceuticals International, plc (KNSA) | Sale (S): 12,000 @ $41.89 | EDGAR |
| 2025-12-10 | 4 | Kiniksa Pharmaceuticals International, plc (KNSA) | Option exercise (M): 16,164 @ $11.10 · Option exercise (M): 16,165 @ $11.97 · Option exercise (M): 10,512 @ $10.76 · Sale (S): 42,841 @ $41.49 · Option exercise (M): 16,164 (derivative) @ $0 · Option exercise (M): 16,165 (derivative) @ $0 · +1 more | EDGAR |
| 2025-11-14 | 4 | Kiniksa Pharmaceuticals International, plc (KNSA) | Option exercise (M): 19,900 @ $30.93 · Sale (S): 19,900 @ $40.94 · Option exercise (M): 19,900 (derivative) @ $0 | EDGAR |
| 2025-10-30 | 4 | Kiniksa Pharmaceuticals International, plc (KNSA) | Option exercise (M): 100 @ $30.93 · Sale (S): 100 @ $41 · Option exercise (M): 100 (derivative) @ $0 | EDGAR |
| 2025-09-03 | 4 | Kiniksa Pharmaceuticals International, plc (KNSA) | Option exercise (M): 1,592 · Option exercise (M): 1,750 · Option exercise (M): 2,694 · Tax withholding (F): 2,920 @ $33.49 · Option exercise (M): 1,861 · Tax withholding (F): 900 @ $34.28 · +6 more | EDGAR |
| 2025-08-06 | 4 | Kiniksa Pharmaceuticals International, plc (KNSA) | Option exercise (M): 18,889 @ $22.89 · Sale (S): 18,889 @ $32.89 · Option exercise (M): 18,889 (derivative) @ $0 | EDGAR |
| 2025-06-05 | 4 | Kiniksa Pharmaceuticals International, plc (KNSA) | Option exercise (M): 18,299 @ $18 · Sale (S): 18,299 @ $28.80 · Option exercise (M): 18,299 (derivative) @ $0 | EDGAR |
| 2025-05-05 | 4 | Kiniksa Pharmaceuticals International, plc (KNSA) | Grant/award (A): 4,558 (derivative) @ $0 · Grant/award (A): 4,786 (derivative) @ $0 · Grant/award (A): 7,368 (derivative) @ $0 · Grant/award (A): 7,606 (derivative) @ $0 | EDGAR |
| 2025-05-01 | 4 | Kiniksa Pharmaceuticals International, plc (KNSA) | Option exercise (M): 20,000 @ $15.52 · Option exercise (M): 22,000 @ $15.50 · Sale (S): 42,000 @ $25.61 · Option exercise (M): 21,254 @ $16.90 · Sale (S): 21,254 @ $26.95 · Option exercise (M): 12,000 @ $17.92 · +7 more | EDGAR |
| 2025-04-29 | 4 | Kiniksa Pharmaceuticals International, plc (KNSA) | Option exercise (M): 990 · Tax withholding (F): 479 @ $21.36 · Option exercise (M): 990 (derivative) @ $0 | EDGAR |
| 2025-04-09 | 4 | Kiniksa Pharmaceuticals International, plc (KNSA) | Option exercise (M): 2,694 · Tax withholding (F): 1,303 @ $20.28 · Option exercise (M): 2,694 (derivative) @ $0 | EDGAR |
| 2025-04-03 | 4 | Kiniksa Pharmaceuticals International, plc (KNSA) | Option exercise (M): 1,750 · Option exercise (M): 1,592 · Tax withholding (F): 847 @ $21.77 · Tax withholding (F): 770 @ $21.77 · Grant/award (A): 29,480 (derivative) @ $0 · Grant/award (A): 7,382 (derivative) @ $0 · +3 more | EDGAR |
| 2025-03-24 | 4 | Kiniksa Pharmaceuticals International, plc (KNSA) | Option exercise (M): 15,944 @ $12.97 · Sale (S): 15,944 @ $23.11 · Option exercise (M): 15,944 (derivative) @ $0 | EDGAR |
| 2025-03-19 | 4 | Kiniksa Pharmaceuticals International, plc (KNSA) | Option exercise (M): 872 · Tax withholding (F): 448 @ $22.61 · Option exercise (M): 11,464 @ $12.97 · Sale (S): 11,464 @ $23.10 · Option exercise (M): 8,879 @ $12.97 · Sale (S): 8,879 @ $23.10 · +3 more | EDGAR |
| 2025-03-14 | 4 | Kiniksa Pharmaceuticals International, plc (KNSA) | Option exercise (M): 36,372 @ $11.97 · Sale (S): 36,372 @ $22.25 · Option exercise (M): 36,372 (derivative) @ $0 | EDGAR |
| 2024-12-10 | 4 | Kiniksa Pharmaceuticals International, plc (KNSA) | Option exercise (M): 2,406 @ $10.76 · Sale (S): 8,969 @ $21.27 · Option exercise (M): 18,860 @ $11.10 · Sale (S): 18,860 @ $21.38 · Option exercise (M): 2,406 (derivative) @ $0 · Option exercise (M): 18,860 (derivative) @ $0 | EDGAR |
| 2024-12-05 | 4 | Kiniksa Pharmaceuticals International, plc (KNSA) | Option exercise (M): 8,969 @ $10.76 · Sale (S): 8,969 @ $21.45 · Option exercise (M): 5,024 @ $10.76 · Sale (S): 5,024 @ $21.25 · Option exercise (M): 1,123 @ $10.76 · Sale (S): 1,123 @ $21.25 · +3 more | EDGAR |
| 2024-09-04 | 4 | Kiniksa Pharmaceuticals International, plc (KNSA) | Option exercise (M): 4,444 · Tax withholding (F): 2,260 @ $26.74 · Option exercise (M): 1,861 · Tax withholding (F): 956 @ $26.74 · Grant/award (A): 6,365 (derivative) @ $0 · Grant/award (A): 33,150 (derivative) @ $0 · +3 more | EDGAR |
| 2024-07-25 | 4 | Kiniksa Pharmaceuticals International, plc (KNSA) | Option exercise (M): 24,248 @ $11.10 · Sale (S): 24,248 @ $24.79 · Option exercise (M): 24,248 (derivative) @ $0 | EDGAR |
| 2024-04-30 | 4 | Kiniksa Pharmaceuticals, Ltd. (KNSA) | Option exercise (M): 991 · Tax withholding (F): 509 @ $17.88 · Option exercise (M): 991 (derivative) @ $0 | EDGAR |
| 2024-04-08 | 4 | Kiniksa Pharmaceuticals, Ltd. (KNSA) | Option exercise (M): 2,694 · Tax withholding (F): 791 @ $17.90 · Grant/award (A): 33,150 (derivative) @ $0 · Grant/award (A): 5,092 (derivative) @ $0 · Grant/award (A): 6,365 (derivative) @ $0 · Option exercise (M): 2,694 (derivative) @ $0 | EDGAR |
| 2024-04-03 | 4 | Kiniksa Pharmaceuticals, Ltd. (KNSA) | Option exercise (M): 1,750 · Tax withholding (F): 514 @ $19.70 · Option exercise (M): 1,750 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1835458 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →